Alaunos Therapeutics Inc (TCRT)

Dec 13, 2024

TCRT stock touches 52-week low at $1.92 amid market challenges - Investing.com

Dec 13, 2024

Nov 15, 2024

Alaunos Therapeutics Inc (TCRT) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 14, 2024

Ziopharm: Q3 Earnings Snapshot - The Washington Post

Nov 14, 2024

Nov 08, 2024

TCRT Stock Touches 52-Week Low at $1.96 Amid Market Challenges - Investing.com Nigeria

Nov 08, 2024

Oct 28, 2024

TCRT stock touches 52-week low at $2.06 amid market challenges - Investing.com

Oct 28, 2024

Oct 13, 2024

Intracranial Therapeutic Market Rewriting its Growth Cycle |Novartis AG, BioMarin, CORESTEM Inc., Alaunos Therapeutics, – IndiaPolitics.com - IndiaPolitics.com

Oct 13, 2024

Oct 11, 2024

After axing its sole clinical prospect last year, Alaunos cuts ties with Precigen - Fierce Biotech

Oct 11, 2024

Oct 11, 2024

Alaunos Therapeutics ends key agreement and updates on financial condition By Investing.com - Investing.com Australia

Oct 11, 2024

Oct 11, 2024

Alaunos Therapeutics Ends Licensing Deal, Reassesses Strategy - Yahoo Finance

Oct 11, 2024

Oct 11, 2024

Precigen reclaims rights after terminating license agreement - Investing.com India

Oct 11, 2024

Oct 10, 2024

Precigen Terminates License Agreement With Alaunos Therapeutics - MarketWatch

Oct 10, 2024

Oct 10, 2024

Alaunos Therapeutics ends key agreement and updates on financial condition - Investing.com

Oct 10, 2024

Oct 01, 2024

Genentech buys Regor’s CDK inhibitors in $850m deal - Clinical Trials Arena

Oct 01, 2024

Sep 26, 2024

AskBio and Belief BioMed partner to advance gene therapies - Pharmaceutical Technology

Sep 26, 2024

Sep 19, 2024

Applied Therapeutics: AdCom Decision Takes Govorestat Approval A Step Closer (NASDAQ:APLT) - Seeking Alpha

Sep 19, 2024

Sep 18, 2024

An Analysis of Atricure Inc (ATRC)’s Potential Price Growth - Knox Daily

Sep 18, 2024

Sep 18, 2024

Applied Therapeutics Surges on Positive FDA Update for Govorestat - BP Journal

Sep 18, 2024

Sep 18, 2024

Applied Therapeutics jumps as US FDA cancels panel meeting for genetic disorder drug - XM

Sep 18, 2024

Sep 18, 2024

Gene Switch / Molecular Switch Market Set to Reach USD 1.44 Billion by 2031 with 9.9% CAGR - WhaTech

Sep 18, 2024

Sep 17, 2024

Daily Market Movement: Atricure Inc (ATRC) Sees a -3.23 Decrease, Closing at 27.30 - The Dwinnex

Sep 17, 2024

Sep 16, 2024

Aptevo Therapeutics announces $3.0M offering priced at-the-market - TipRanks

Sep 16, 2024

Sep 16, 2024

Check out these key findings about Atricure Inc (ATRC) - SETE News

Sep 16, 2024

Sep 14, 2024

Atmos Energy Co. (NYSE:ATO) Shares Sold by Prudential PLC - MarketBeat

Sep 14, 2024

Sep 11, 2024

Gilead and Genesis partner to create novel therapies using AI - Pharmaceutical Technology

Sep 11, 2024

Aug 28, 2024

Navigator gains $100m in Series A funding for antibody therapeutics - Pharmaceutical Technology

Aug 28, 2024

Aug 23, 2024

VION Biosciences acquires Echelon Biosciences - Pharmaceutical Technology

Aug 23, 2024

Aug 17, 2024

TCRT stock touches 52-week low at $2.28 amid market challenges - Investing.com India

Aug 17, 2024

Aug 16, 2024

Ziopharm: Q2 Earnings Snapshot - San Antonio Express-News

Aug 16, 2024

Aug 14, 2024

Eli Lilly inaugurates R&D facility in Boston, US - Pharmaceutical Technology

Aug 14, 2024

Aug 07, 2024

Alaunos Therapeutics (NASDAQ:TCRT) Trading Down 4.2% - Defense World

Aug 07, 2024

Aug 07, 2024

Genentech and Sangamo to develop neurodegenerative disease therapies - Pharmaceutical Technology

Aug 07, 2024

Jul 29, 2024

TCRT stock touches 52-week low at $3.57 amid market challenges - Investing.com Nigeria

Jul 29, 2024

Jul 17, 2024

Alaunos Therapeutics announces 1-for-10 reverse stock split By Investing.com - Investing.com Australia

Jul 17, 2024

Jul 16, 2024

Alaunos Therapeutics announces 1-for-10 reverse stock split - Investing.com

Jul 16, 2024

Jul 11, 2024

XyloCor taps SmartWise’s infusion device for gene therapy administration - Clinical Trials Arena

Jul 11, 2024

Jul 04, 2024

Intracranial Therapeutic Industry Startegy Analysis} Novartis AG, BioMarin, CORESTEM Inc., Alaunos Therapeutics ... - Economica

Jul 04, 2024

Jun 27, 2024

Alaunos (TCRT) Dips More Than Broader Markets: What You Should Know - Yahoo New Zealand News

Jun 27, 2024

Jun 26, 2024

Zacks Industry Outlook Highlights Dyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings ... - Yahoo Lifestyle UK

Jun 26, 2024

Jun 22, 2024

Alaunos Therapeutics appoints new accounting firmInvesting.com ZA - Investing.com South Africa

Jun 22, 2024

Jun 21, 2024

Alaunos Therapeutics appoints new accounting firm By Investing.com - Investing.com

Jun 21, 2024

Jun 20, 2024

Ziopharm Oncology to Participate in Upcoming Conferences - Quantisnow

Jun 20, 2024

Jun 20, 2024

Ziopharm Oncology to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast on February 25 ... - Quantisnow

Jun 20, 2024

Jun 17, 2024

Alaunos Therapeutics Appoints Abhishek Srivastava, Ph.D. as Vice President, Technical Operations - Quantisnow

Jun 17, 2024

May 29, 2024

Turn Bio and HanAll to develop therapies for age-related conditions - Pharmaceutical Technology

May 29, 2024

May 22, 2024

AltruBio secures $225m for immune checkpoint programme development - Pharmaceutical Technology

May 22, 2024

Mar 27, 2024

Avenzo Therapeutics secures $150m to bolster oncology pipeline - Pharmaceutical Technology

Mar 27, 2024

Mar 25, 2024

Gilead concludes acquisition of CymaBay Therapeutics for $4.3bn - Pharmaceutical Technology

Mar 25, 2024